The Value of Modular Design in Pharma-Grade ODF Production Lines
Share
In the manufacturing of pharmaceuticals and functional foods, building an Oral Dissolvable Film (ODF) production line often requires balancing R&D validation, pilot-scale trials, and commercial-scale production. Ensuring a smooth transition across these stages is a common challenge for companies during scale-up and regulatory registration. Modular design in ODF production lines provides the ideal solution to this issue.
Why Modular Design Matters
- Reduce initial investment: No need to invest in a full commercial line during the R&D stage.
- Support process validation: Pilot-scale production can validate processes before scaling to commercial lines.
- Flexible expansion: Easily upgrade by adding or replacing modules as capacity grows.
Common Industry Pain Points
- One-size-fits-all lines: Using different equipment for R&D, pilot, and production causes repeated investment.
- Process inconsistency: Scale differences lead to deviations that complicate regulatory validation.
- Lengthy expansion cycles: Without modular design, every scale-up requires new procurement, installation, and debugging.
HUANGHAI’s Modular Solution
- Modular line layout: Covers coating, drying, cutting, and packaging with expandable modules tailored to customer needs.
- Smooth R&D-to-production transition: The pilot model (MJ150-L) and commercial model (MJ150) share the same process logic, ensuring comparable data and compliance continuity.
- Reduced validation risk: Modular design minimizes process deviations during scale-up, supporting GMP audit requirements.
Compliance and Quality Benefits
- Ensures traceability and consistency across production stages.
- Provides continuous data for regulatory registration and process validation.
- Enhances flexibility and cost efficiency throughout the product lifecycle.
Recommended Equipment
Conclusion
Modular design provides flexibility, scalability, and compliance assurance for pharma-grade ODF production lines. From R&D to commercialization, every stage can smoothly transition under a unified process logic. HUANGHAI’s modular ODF solutions help reduce investment risks, shorten scale-up timelines, and accelerate the path from lab to market.
*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.
Frequently Asked Questions
Q: What is the difference between an ODF film and a transdermal patch?
A: Oral Dissolving Films (ODF) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar solvent-cast film coating processes. Huanghai's MJ150 ODF machine supports both applications on a single platform with approximately 2 working days of changeover time.
Q: What production output can I expect from a Huanghai ODF machine?
A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either machine with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.
Q: What drying technology does Huanghai use for ODF production?
A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform film thickness, reduced edge curl, and better API distribution across the film web. An optional far-infrared heating module adds 20–30% drying efficiency for solvent-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ODF equipment supplier to Sinopharm, Shanghai Pharma, and Fosun Pharma.
Q: What are the GMP requirements for ODF production equipment?
A: ODF manufacturing equipment must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent standards (EU GMP Annex 1, ChGMP) for other markets. Key requirements: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; data integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ODF machines meet these standards—all product contact surfaces use pharmaceutical-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP compliance documentation.
For a full overview of the certifications and compliance standards our equipment meets, see our Certifications & Compliance page.
Q: Can Huanghai machines produce stripe-coated or multi-formula ODF films?
A: Yes. Huanghai holds a patent for multi-formula stripe coating (Patent CN117323228A), enabling two different API formulations to be applied side-by-side in a single coating pass. This eliminates the need for multiple coating/drying cycles when producing combination-drug ODF products. Competitors require manual multi-layer coating with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-API ODFs for cardiovascular or CNS indications) where coating efficiency directly impacts production economics.
Explore Complete ODF & TDDS Manufacturing Solutions
Huanghai offers end-to-end ODF film production lines — from lab-scale R&D (BY-300A / MJ150-L) to commercial manufacturing (MJ150). GMP-certified and 21 CFR Part 11 compliant.